India, with its booming economy, huge population, and large pool of well-educated, English-speaking medical professionals is rapidly becoming a preferred destination for clinical trials. India’s economy is growing at an annual rate of about 8%—second only to China—and healthcare and pharmaceuticals are among the fastest growing sectors. The health care industry is growing at a rate of nearly 15% per year and is expected to be worth $200 billion in value by 2022.